ArticleBMC surgery2026
Minimally invasive resection rectopexy as a treatment method for obstructive defecation (ODS): functional outcome in ODS; constipation and fecal incontinence.
Article in BMC surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundMinimally invasive resection rectopexy is an effective treatment for obstructive defecation syndrome (ODS) in carefully selected patients, offering favorable functional outcomes with potentially reduced surgical trauma. As minimally invasive techniques continue to advance in colorectal surgery, integrating resection rectopexy with Natural Orifice Specimen Extraction (NOSE) or minilaparotomy retrieval may further enhance postoperative bowel function by minimizing constipation and fecal incontinence. We hypothesize that surgical outcomes are influenced by the severity of disease.
methodsBetween January 2019 and June 2022, 85 patients with ODS underwent minimally invasive resection rectopexy. Patient characteristics were assessed using standardized questionnaires. Surgical outcomes, complications, and patient satisfaction were evaluated at 1, 3, and 6 months postoperatively. Symptom severity was quantified using the Wexner Constipation Score (WCS), Wexner Incontinence Score (WIS), and Altomare Obstructive Defecation Syndrome (AOS) Score. Repeated measures ANOVA was performed to assess longitudinal changes in these measures over time.
resultsAll procedures were successfully completed laparoscopically without conversion. The mean patient age was 58.5 years (SD = 16.5). Complications were classified as Clavien-Dindo grade IIIa (n = 3), IIIb (n = 8), and IVa (n = 1). Repeated measures ANOVA demonstrated significant postoperative improvements in WCS (p < 0.0001) and AOS (p < 0.0001). Although WIS changes were not statistically significant, a gender-specific effect was observed (p = 0.011). Post hoc analyses revealed no significant temporal effects for WIS across genders. Follow-up was limited to 6 months.
conclusionMinimally invasive resection rectopexy provides substantial symptom relief, particularly in reducing constipation and obstructive defecation. While outcomes for fecal incontinence remain variable, the procedure seems safe, feasible, and markedly improves the quality of life in patients with ODS. Long-term outcomes and recurrence rates require further study.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.